Literature DB >> 8882780

Delineation of the Marfan phenotype associated with mutations in exons 23-32 of the FBN1 gene.

E A Putnam1, M Cho, A B Zinn, J A Towbin, P H Byers, D M Milewicz.   

Abstract

Marfan syndrome is a dominantly inherited connective tissue disorder with a wide range of phenotypic severity. The condition is the result of mutations in FBN1, a large gene composed of 65 exons encoding the fibrillin-1 protein. While mutations causing classic manifestations of Marfan syndrome have been identified throughout the FBN1 gene, the six previously characterized mutations resulting in the severe, perinatal lethal form of Marfan syndrome have clustered in exons 24-32 of the gene. We screened 8 patients with either neonatal Marfan syndrome or severe cardiovascular complications of Marfan syndrome for mutations in this region of the gene. Using intron-based exon-specific primers, we amplified exons 23-32 from genomic DNAs, screened these fragments by single-stranded conformational polymorphism analysis, and sequenced indicated exons. This analysis documented mutations in exons 25-27 of the FBN1 gene in 6 of these patients. These results, taken together with previously published FBN1 mutations in this region, further define the phenotype associated with mutations in exons 24-32 of the FBN1 gene, information important for the development of possible diagnostic tests and genetic counseling.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8882780     DOI: 10.1002/(SICI)1096-8628(19960329)62:3<233::AID-AJMG7>3.0.CO;2-U

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  35 in total

1.  New fibrillin gene mutation - possible cause of ascending aortic dilation in patients with aortic valve disease: Preliminary results.

Authors:  Ján Dudra; Jaroslav Lindner; Ivan Vaněk; Jana Simova; Ivan Mazura; Ivo Miler; Jana Ciháková; Pavel Capek; Josef Belák
Journal:  Int J Angiol       Date:  2009

2.  Marfan Database (second edition): software and database for the analysis of mutations in the human FBN1 gene.

Authors:  G Collod-Béroud; C Béroud; L Adès; C Black; M Boxer; D J Brock; M Godfrey; C Hayward; L Karttunen; D Milewicz; L Peltonen; R I Richards; M Wang; C Junien; C Boileau
Journal:  Nucleic Acids Res       Date:  1997-01-01       Impact factor: 16.971

Review 3.  Marfan syndrome in the third Millennium.

Authors:  Gwenaëlle Collod-Béroud; Catherine Boileau
Journal:  Eur J Hum Genet       Date:  2002-11       Impact factor: 4.246

4.  Fibulin-4: a novel gene for an autosomal recessive cutis laxa syndrome.

Authors:  Vishwanathan Hucthagowder; Nina Sausgruber; Katherine H Kim; Brad Angle; Lihua Y Marmorstein; Zsolt Urban
Journal:  Am J Hum Genet       Date:  2006-04-10       Impact factor: 11.025

5.  In vivo studies of mutant fibrillin-1 microfibrils.

Authors:  Noe L Charbonneau; Eric J Carlson; Sara Tufa; Gerhard Sengle; Elise C Manalo; Valerie M Carlberg; Francesco Ramirez; Douglas R Keene; Lynn Y Sakai
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

6.  Parental somatic and germ-line mosaicism for a FBN2 mutation and analysis of FBN2 transcript levels in dermal fibroblasts.

Authors:  E A Putnam; E S Park; C M Aalfs; R C Hennekam; D M Milewicz
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

7.  A rare branch-point mutation is associated with missplicing of fibrillin-2 in a large family with congenital contractural arachnodactyly.

Authors:  C Maslen; D Babcock; M Raghunath; B Steinmann
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

8.  Recurrence of Marfan syndrome as a result of parental germ-line mosaicism for an FBN1 mutation.

Authors:  T Rantamäki; I Kaitila; A C Syvänen; M Lukka; L Peltonen
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

9.  Identification of the minimal combination of clinical features in probands for efficient mutation detection in the FBN1 gene.

Authors:  Chantal Stheneur; Gwenaëlle Collod-Béroud; Laurence Faivre; Jean François Buyck; Laurent Gouya; Jean-Marie Le Parc; Bertrand Moura; Christine Muti; Bernard Grandchamp; Gilles Sultan; Mireille Claustres; Philippe Aegerter; Bertrand Chevallier; Guillaume Jondeau; Catherine Boileau
Journal:  Eur J Hum Genet       Date:  2009-03-18       Impact factor: 4.246

10.  Prevalence data on all Ghent features in a cross-sectional study of 87 adults with proven Marfan syndrome.

Authors:  Svend Rand-Hendriksen; Rigmor Lundby; Lena Tjeldhorn; Kai Andersen; Jon Offstad; Svein Ove Semb; Hans-Jørgen Smith; Benedicte Paus; Odd Geiran
Journal:  Eur J Hum Genet       Date:  2009-03-18       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.